Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

NCT00823966 · clinicaltrials.gov ↗

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Rescriptor

Sponsor

Pfizer